Cargando…

Insufficiency of Mrpl40 disrupts testicular structure and semen parameters in a murine model

Approximately 31% of patients with 22q11.2 deletion syndrome (22q11.2DS) have genitourinary system disorders and 6% of them have undescended testes. Haploinsufficiency of genes on chromosome 22q11.2 might contribute to the risk of 22q11.2DS. In this study, we used mice with single-allele deletion in...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Ying, Fu, Long-Long, Xu, Hui-Zhong, Zheng, Yi-Ming, Li, Wei-Xi, Qian, Guang-Hui, Lu, Wen-Hong, Lv, Hai-Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10521951/
https://www.ncbi.nlm.nih.gov/pubmed/36891938
http://dx.doi.org/10.4103/aja2022119
Descripción
Sumario:Approximately 31% of patients with 22q11.2 deletion syndrome (22q11.2DS) have genitourinary system disorders and 6% of them have undescended testes. Haploinsufficiency of genes on chromosome 22q11.2 might contribute to the risk of 22q11.2DS. In this study, we used mice with single-allele deletion in mitochondrial ribosomal protein L40 (Mrpl40(+/−)) as models to investigate the function of Mrpl40 in testes and spermatozoa development. The penetrance of cryptorchidism in Mrpl40(+/−) mice was found to be higher than that in wild-type (WT) counterparts. Although the weight of testes was not significantly different between the WT and Mrpl40(+/−) mice, the structure of seminiferous tubules and mitochondrial morphology was altered in the Mrpl40(+/−) mice. Moreover, the concentration and motility of spermatozoa were significantly decreased in the Mrpl40(+/−) mice. In addition, data-independent acquisition mass spectrometry indicated that the expression of genes associated with male infertility was altered in Mrpl40(+/−) testes. Our study demonstrated the important role of Mrpl40 in testicular structure and spermatozoa motility and count. These findings suggest that Mrpl40 is potentially a novel therapeutic target for cryptorchidism and decreased motility and count of spermatozoa.